PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2014.46.2.1722014462172-177Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin TreatmentJung Hyun Lee, Sung Gu Kang, Seung Tae Kim, Seok Ho Kang, In Keun Choi, Young Je Park, Sang Chul Oh, Deuk Jae Sung, Jae Hong Seo, Jun Cheon, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim, Kyong Hwa Parkhttp://www.e-crt.org/upload/pdf/crt-46-172.pdf, http://www.e-crt.org/upload/pdf/crt-46-172.pdf
International Journal of Urology10.1111/j.1442-2042.2007.01889.x200714111000-1004Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinomaKazumasa Matsumoto, Akira Irie, Takefumi Satoh, Miyoko Okazaki, Masatsugu Iwamura, Shiro Babahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1442-2042.2007.01889.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2007.01889.x/fullpdf
Bulletin du Cancer10.1016/s0007-4551(20)30280-020201075eS1-eS7Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAveMarine Gross-Goupil, Charlotte Domblides, Felix Lefort, Alain Ravaudhttps://api.elsevier.com/content/article/PII:S0007455120302800?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0007455120302800?httpAccept=text/plain
BMC Cancer10.1186/s12885-015-1825-52015151Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)Ki Hong Kim, Sung Joon Hong, Kyung Seok Hanhttp://link.springer.com/content/pdf/10.1186/s12885-015-1825-5.pdf, http://link.springer.com/article/10.1186/s12885-015-1825-5/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12885-015-1825-5.pdf
10.21203/rs.3.rs-164451/v12021Comparison of Clinical Outcomes in Patients With Localized or Locally Advanced Urothelial Carcinoma Treated With Neoadjuvant Chemotherapy Involving Gemcitabine-Cisplatin and High Dose-Intensity MVACYongjune Lee, Young Seok Kim, Bumsik Hong, Yong Mee Cho, Jae-Lyun Leehttps://www.researchsquare.com/article/rs-164451/v1, https://www.researchsquare.com/article/rs-164451/v1.html
Value in Health10.1016/j.jval.2018.09.268201821S46PCN185 - COST-EFFECTIVENESS OF NIVOLUMAB IN SECOND-LINE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA IN ADULTS AFTER FAILURE OF PRIOR PLATINUM-CONTAINING THERAPY IN GREECES. Boukouvalas, F. Diamantogiannis, E. Basta, S. Stephenshttps://api.elsevier.com/content/article/PII:S109830151833568X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S109830151833568X?httpAccept=text/plain
ECB 202110.3390/ecb2021-102752021Ramucirumab as a Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: A Meta-Analysis of Randomized Clinical TrialsIrena Ilic, Milena Ilichttps://www.mdpi.com/2673-9976/7/1/14/pdf
European Urology Supplements10.1016/s1569-9056(14)61336-12014135152-153P113 Design of an exploratory phase I study of pemetrexed in addition to vinflunine as second-line treatment in patients with metastatic urothelial cell carcinoma after prior treatment with platinumH. Pappot, H. Von Der Maase, A. Ullen, M. Agerbæk, NUCOGhttps://api.elsevier.com/content/article/PII:S1569905614613361?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1569905614613361?httpAccept=text/plain
Clinical Colorectal Cancer10.3816/ccc.2007.n.033200769646-651Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group StudyAlex Y. Chang, Gilberto Lopes, Koo Wen Hsin, Robert Lim, Foo Kian Fong, John Wonghttps://api.elsevier.com/content/article/PII:S153300281170305X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S153300281170305X?httpAccept=text/plain
Journal of Urology10.1016/j.juro.2015.09.005201519461583-1585Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial CarcinomaSam S. Changhttps://api.elsevier.com/content/article/PII:S0022534715047242?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022534715047242?httpAccept=text/plain, http://www.jurology.com/doi/pdf/10.1016/j.juro.2015.09.005